BioAge Labs, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from BioAge Labs, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Cash Cushion Ratio: Cash, after subtracting all debt, is 1.1 times its market value (net cash). Higher than 90% of Healthcare companies in United States.
- Steadiness Ratio: Sales grew in 1 of the last 3 years; profit grew in 0 of 3. Less steady than 86% of Healthcare companies in United States.
- Self-Funding Ratio: Over the last 3 years operating cash was negative while the company kept spending on investment (capex). Lower than 85% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-136.3×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 85% of Healthcare companies in United States.
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
1/3 · 0/3Sales grew in 1 of the last 3 years; profit grew in 0 of 3.
Less steady than 86% of Healthcare companies in United States.
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
-30.8×Operating cash was negative last year, while some debt falls due within a year.
Lower than 64% of Healthcare companies in United States.
Cash Cushion Ratio
1.1× cashCash, after subtracting all debt, is 1.1 times its market value (net cash).
Higher than 90% of Healthcare companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (12)
BioAge Labs, Inc. made a loss over the last year. BioAge Labs, Inc. owes $0.06 for every $1 it owns. BioAge Labs, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossBioAge Labs, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
0.68The share price is 0.68 times BioAge Labs, Inc.'s book value per share, lower than 87% of Healthcare companies in United States.
Market cap
$254 MThe total market value of all of BioAge Labs, Inc.'s shares at today's price (share price × number of shares), smaller than 54% of Healthcare companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
$375 MWhat BioAge Labs, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$8.17Net worth divided by the number of shares. The share price of $5.53 is 0.7 times this, which is the P/B above.
Return on equity (ROE)
-28.2%BioAge Labs, Inc. lost 28.2% of its shareholders' money over the last year, higher than 61% of Healthcare companies in United States.
Owes vs Owns
0.06×BioAge Labs, Inc. owes $0.06 for every $1 it owns (low), lower than 96% of Healthcare companies in United States.
Dividend yield
NoneBioAge Labs, Inc. does not currently pay a dividend.
Profit growth
LossBioAge Labs, Inc. made a loss in each of the last two years.
Profit margin
-896.1%BioAge Labs, Inc. lost $896 for every $100 of revenue.
Interest cover
Not coveredBioAge Labs, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net cashBioAge Labs, Inc. held $276 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For BioAge Labs, Inc.: $254 M ÷ $375 M (30 Jun 2026) = 0.7.
What is BioAge Labs, Inc.'s return on equity?
BioAge Labs, Inc. lost 28.2% of its shareholders' money over the last year, higher than 61% of Healthcare companies in United States.
How much does BioAge Labs, Inc. owe compared with what it owns?
BioAge Labs, Inc. owes $0.06 for every $1 it owns (low), lower than 96% of Healthcare companies in United States.
Does BioAge Labs, Inc. pay a dividend?
No. BioAge Labs, Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.